Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

Transglutaminase 2 (TG2), a cross-linking enzyme, is involved in drug resistance and in the constitutive activation of nuclear factor kappa B (NF-κB). We investigated the association of non-small cell lung cancer (NSCLC) treatment efficacy with TG2 and NF-κB expression in 120 patients: 102 with aden...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Jae-Heon, Cho, Byoung Chul, Shim, Hyo Sup, Kim, Hye-Ryun, Lim, Sun-Min, Kim, Se Kyu, Chung, Kyung Young, Islam, S.M. Bakhtiar Ul, Song, Jae Jin, Kim, Soo-Youl, Kim, Joo Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708070/
https://www.ncbi.nlm.nih.gov/pubmed/23853482
http://dx.doi.org/10.3346/jkms.2013.28.7.1005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708070/
https://www.ncbi.nlm.nih.gov/pubmed/23853482
http://dx.doi.org/10.3346/jkms.2013.28.7.1005

Ejemplares similares